ArticleThe Journal of investigative dermatology2022
An Epidemiologic Analysis of Melanoma Overdiagnosis in the United States, 1975-2017.
Article in The Journal of investigative dermatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 2 syntheses or guidelines pooled it, 59 citations in OpenAlex.
- A systematic review of microsimulation models for skin cancer.BMC medical informatics and decision making · 2025Pooled it
- Pooled it
- Melanoma disparities in Utah: Disproportionate rates among Hispanic and non-White populations in a population-based analysis.JAAD international · 2026Article
- Overdiagnosis of Melanoma In Situ.Journal of clinical medicine · 2026Review
- Article
- Bridging gaps throughout a patient's journey with melanoma: a systematic review.Melanoma management · 2025Review
- Automated triage of cancer-suspicious skin lesions with 3D total-body photography.NPJ digital medicine · 2025Article
- Socioeconomic Influences on Melanoma Incidence Patterns by Stage in the US.Journal of surgical oncology · 2025Article
- Screening and novel diagnostic technologies for melanoma: an update.Melanoma management · 2025Review
- Environmental consequences of interacting effects of changes in stratospheric ozone, ultraviolet radiation, and climate: UNEP Environmental Effects Assessment Panel, Update 2024.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2025Article
- Declining Clinical Utility of Tools for Predicting Sentinel Lymph Node Biopsy Status: A Single Institution Experience from 2000 to 2021.Annals of surgical oncology · 2025Article
- Incidence of melanoma in situ among racial and ethnic minorities in the United States.JAAD international · 2025Article
- Article
- Differential time series analysis shows deceleration in melanoma mortality prior to the widespread use of highly effective therapies.Journal of the American Academy of Dermatology · 2024Article
- Skin Cancer Care in US Veterans-Serving Those Who Served.JAMA dermatology · 2024Article
- Deceptive Measures of "Success" in Early Cancer Detection.Current oncology (Toronto, Ont.) · 2024Review
- Acral Melanoma Incidence and Survival Trends in 1990-2020: A Nationwide, Population-based Study.Acta dermato-venereologica · 2024Article
- Dermatoscopic features and potential pitfalls of artificial intelligence-based analysis of benign acral pigmented lesions in Black patients: A multicenter observational study.Journal of the American Academy of Dermatology · 2024Observational
- A Narrative Review of Current Knowledge on Cutaneous Melanoma.Clinics and practice · 2024Review
- Overdiagnosis in Melanoma Screening: Is It a Real Problem?Dermatology practical & conceptual · 2023Article
Corrections and comments
- Commented on by
Authors and funding
8 authors at 3 institutions in 1 country.
Funding
Abstract
The primary cause of the increase in melanoma incidence in the United States has been suggested to be overdiagnosis. We used Surveillance, Epidemiology, and End Result Program data from 1975 to 2017 to examine epidemiologic trends of melanoma incidence and mortality and better characterize overdiagnosis in white Americans. Over the 43-year period, incidence and mortality showed discordant temporal changes across population subgroups; trends most suggestive of overdiagnosis alone were present in females aged 55-74. Other groups showed mixed changes suggestive of overdiagnosis plus changes in underlying disease risk (decreasing risk in younger individuals and increasing risk in older males). Cohort effects were identified for male and female mortality and male incidence but were not as apparent for female incidence, suggesting that period effects have had a greater influence on changes in incidence over time in females. Encouraging trends included long-term declines in mortality in younger individuals and recent stabilization of invasive incidence in individuals aged 15-44 years and males aged 45-54 years. Melanoma in situ incidence, however, has continued to increase throughout the population. Overdiagnosis appears to be relatively greater in American females and for melanoma in situ.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.